Structural analysis of impurities in pharmaceutical ingredients using trap-free 2D-LC high-resolution accurate mass spectrometry

Significance of the topic

Impurity profiling is essential for ensuring pharmaceutical safety and regulatory compliance. Non-volatile mobile phases offer improved chromatographic performance but cannot be directly coupled to mass spectrometry. Trap-free two-dimensional liquid chromatography (2D-LC) bridges this gap by enabling direct exchange to MS-compatible volatile phases without sample loss, facilitating high-resolution structural elucidation.

Objectives and Study Overview

The study demonstrates the utility of a trap-free 2D-LC system coupled to quadrupole time-of-flight mass spectrometry (QTOF MS) for structural analysis of trace impurities in atorvastatin calcium hydrate, employing the unmodified Japanese Pharmacopoeia HPLC method.

Methodology and Instrumentation

First-dimension separation was performed under non-volatile mobile phase conditions using HPLC-UV to resolve atorvastatin and its impurities. Peak capture loops collected individual fractions. These fractions were then subjected to a second-dimension separation with a volatile mobile phase (ammonium formate–water and acetonitrile) and directly introduced into the QTOF MS for accurate mass and MS/MS analysis.

Instrumentation

• Shimadzu LCMS-9030 system with trap-free 2D-LC configuration
• Shim-pack VP-ODS column for first-dimension HPLC-UV
• Shim-pack XR-ODS column for second-dimension QTOF analysis

Key Results and Discussion

UV detection in the first dimension revealed sixteen chromatographic peaks, including the main atorvastatin component. Subsequent QTOF MS analysis in both positive and negative electrospray ionization modes achieved mass accuracy within 1 ppm, confirming the identities of atorvastatin and European Pharmacopoeia-listed impurities. MS/MS fragmentation of impurity F enabled automated structural assignment using dedicated prediction software, demonstrating comprehensive structural elucidation.

Benefits and Practical Applications

• Maintains original chromatographic conditions while enabling mass spectrometric compatibility
• Enhances confidence in impurity identification with high–resolution accurate mass data
• Streamlines impurity profiling workflows for pharmaceutical quality control

Future Trends and Opportunities

Advances may include integration of automated data interpretation tools, application to more complex drug formulations, coupling with alternative high-resolution mass analyzers, and real-time impurity monitoring for process control.

Conclusion

Trap-free 2D-LC coupled with QTOF MS provides a robust platform for structural analysis of pharmaceutical impurities under standard HPLC conditions, combining superior chromatographic separation with high-resolution mass spectrometric detection.